Leganto

Medicinal product

(Invented) name

Leganto

Active substance (s)

Rotigotinas

Strength

6 mg/24 h

Pharmaceutical form

transderminis pleistras

Route (s) of administration

vartoti per odą

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BC09, Rotigotine

Marketing authorisation holder

UCB Pharma S.A., Belgija

Date of authorisation

2011-06-16

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Transdermal patch	1 vnt.
Rotigotinas	6 mg/24 h

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47467	61284	1061284	paketėlis	N7		Receptinis	EU/1/11/695/037	Netiekiama	-	-	No	-	-
47469	61286	1061286	paketėlis	N28		Receptinis	EU/1/11/695/039	Netiekiama	-	-	No	-	-
47470	61287	1061287	paketėlis	N30		Receptinis	EU/1/11/695/040	Netiekiama	-	-	No	-	-
47473	61290	1061290	paketėlis	N84 (sudėtinė 2x42)		Receptinis	EU/1/11/695/043	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-12-13	Išregistruotas
2011-06-16	Registruotas